Anti-cancer chemotherapeutic agent inhibits glioblastoma growth and radiation resistance

Glioblastoma is a primary brain tumour with dismal survival rates, even after treatment with surgery, chemotherapy and radiotherapy. A small subpopulation of tumour cells — glioma stem cells — is responsible for glioblastoma’s tumourigenesis, treatment resistance and subsequent tumour recurrence.
EurekAlert